Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

April 3, 2018News

A New Framework for Evaluating – and Encouraging – Industry’s IP-Sharing Activities for Global Health

BIOtech Now Rufael Seyum The Access to Medicine Foundation and BIO Ventures for Global Health (BVGH) teamed up to publish a new […]

March 29, 2018News

One Health: Biotechnology Sector Ready to Act

BIOtech Now Connor McKoy Globalization has changed our models of disease. Emerging health threats throughout the world have the potential to impact […]

March 23, 2018News

ICYMI: 340B: Good Intentions, Wrong Path

BIOtech Now Andrew Segerman It’s been 25 years since Congress created the 340B Drug Discount Program – a program designed to provide […]

March 16, 2018News

President’s Cancer Panel Recommends Shift Towards Value

BIOtech Now Andrew Segerman This week, the President’s Cancer Panel published a new report entitled “Promoting Value, Affordability, and Innovation in Cancer […]

March 14, 2018News

ICER Comes Under Renewed Scrutiny

BIOtech Now Andrew Segerman As we enter a new and exciting era of medicine, there is an important question we need to […]

March 8, 2018News

Different Perspectives for AHIP to Consider During Today’s Discussion on Drug Costs

BIOtech Now Ken Lisaius This week, America’s Health Insurance Plans, or AHIP, is hosting its annual health policy conference. Included in the […]

March 7, 2018News

Preparing for the Next Public Health Emergency

BIOtech Now Andrew Segerman The weather report shows a 50 percent chance of rain tomorrow. Should you pack an umbrella just in […]

March 5, 2018News

Secretary Azar Talks Opioid Strategy with NGA

BIOtech Now Andrew Segerman Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and abuse in America. […]

March 2, 2018News

Reps. Upton and Dingell on Solving America’s Opioid Crisis

BIOtech Now Andrew Segerman Writing this morning for the Detroit Free Press, Reps. Fred Upton (R-MI) and Debbie Dingell (D-MI) reinforce the need […]

February 27, 2018News

Biotech is key to Achieving International Trilateral Group’s Goals

BIOtech Now George Goodno This week in Geneva three key UN agencies are meeting to address and advance their shared mission of […]

February 21, 2018News

Innovation (at Home and in the Lab) Can Reduce Your Heart-Attack Risk

BIOtech Now Jim Greenwood Over the last decade, I’ve become increasingly conscious of maintaining my cardiovascular health, making dietary changes and keeping […]

February 19, 2018News

New Infographic: Balancing Need for Innovation with Competition

BIOtech Now George Goodno It is an underreported fact that the time it takes for a generic medicine to come to market […]

February 16, 2018News

BIO Unveils Refreshed Advocate Toolkit

BIOtech Now Joe Hansen This past March, BIO launched DrugCostFacts.org, an interactive web tool designed to help policymakers, members of the media and […]

February 15, 2018News

Save the Date: Human Genome Editing Webinar with NAS/NAM, FDA on February 22

BIOtech Now Andrew Segerman DNA defines who we are. And like anything else, sometimes there are mistakes – mutations in genes that […]

February 14, 2018News

The Remedy to Beating America’s Opioid Crisis

BIOtech Now Andrew Segerman Opioid abuse and addiction is one of the worst public health crises America has ever faced. The solution, […]

February 13, 2018News

#BIOCEO18: Tackling the Opioid Crisis

BIOtech Now Daniel Seaton Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated families and economic […]

February 12, 2018News

#BIOCEO18 “A Moment Decades in the Making”

BIOtech Now Brian Newell It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking yet another critical […]

February 9, 2018News

Is Your Emergency Worth It? Let’s Ask Your Insurer…

BIOtech Now Andrew Segerman Imagine that it is 2AM and the pain is so severe that you cannot move. At this point, […]

February 7, 2018News

Give It a Shot – Protect Yourself from the Flu

BIOtech Now Andrew Segerman Everyday it’s a new headline. The numbers keep rising. No, we’re not talking about the latest lottery jackpot. […]

February 5, 2018News

340B Drug Discount Program At-A-Glance

BIOtech Now Andrew Segerman In 1992, with the support of the biopharmaceutical industry, Congress created the 340B Drug Discount Program to help […]

Posts navigation

< 1 … 36 37 38 … 47 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • How can proteomic analysis improve our understanding of the ageing process. Find out in your latest issue of BioTechniques!
  • Mutated gene is the driver of psoriasis
  • The latest developments in microbiology from a diverse cast of characters
  • Scientists stymie sarcopenia
  • Decoding the neuroanatomical signature of developmental language disorder
  • Lac-Phe: the mechanism behind metformin’s role in weight loss
© 2025 V-Biognostics. Proudly powered by Sydney